MicroRNAs as markers of progression in cervical cancer: a systematic review
- PMID: 29945565
- PMCID: PMC6020348
- DOI: 10.1186/s12885-018-4590-4
MicroRNAs as markers of progression in cervical cancer: a systematic review
Abstract
Background: Invasive cervical cancer (ICC) is caused by high-risk human papillomavirus types (HR-HPVs) and is usually preceded by a long phase of intraepithelial neoplasia (CIN). Before invasion, (epi) genetic changes, potentially applicable as molecular markers within cervical screening, occur in HPV host cells. Epigenetic alterations, such as dysregulation of microRNA (miRNA) expression, are frequently observed in ICC. The mechanisms and role of miRNA dysregulation in cervical carcinogenesis are still largely unknown.
Methods: We provide an overview of the studies investigating miRNA expression in relation to ICC progression, highlighting their common outcomes and their weaknesses/strengths. To achieve this, we systematically searched through Pubmed database all articles between January 2010 and December 2017.
Results: From the 24 studies retrieved, miR-29a and miR-21 are the most frequently down- and up-regulated in ICC progression, respectively. Microarray-based studies show a small overlap, with miR-10a, miR-20b, miR-9, miR-16 and miR-106 found repeatedly dysregulated. miR-34a, miR-125 and miR-375 were also found dysregulated in cervical exfoliated cells in relation to cancer progression.
Conclusions: The pivotal role of miRNAs in ICC progression and initial development is becoming more and more relevant. Available studies are essentially based on convenience material, entailing possible selection bias, and frequently of small size: all these points still represent a limitation to a wide comprehension of miRNAs relevant for ICC. The targeted approach instead of a genome-wide investigation still precludes the identification of all the relevant miRNAs in the process. The implementation of deep sequencing on large scale population-based studies will help to discover and validate the relation between altered miRNA expression and CC progression for the identification of biomarkers. Optimally, once explored on a miRNome scale, small specific miRNA signatures maybe used in the context of screening.
Keywords: Cancer progression; Cervical cancer; Cervical intraepithelial neoplasia (CIN) lesions; HPV infection; Microarray; microRNA; qPCR.
Conflict of interest statement
Not applicable to this study.
Competing interests
The authors declare that they do not have any competing interest.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures


Similar articles
-
microRNAs are biomarkers of oncogenic human papillomavirus infections.Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4262-7. doi: 10.1073/pnas.1401430111. Epub 2014 Mar 3. Proc Natl Acad Sci U S A. 2014. PMID: 24591631 Free PMC article.
-
[The role of microRNAs in the pathogenesis of cervical cancer and its relationship to HPV].Sheng Li Ke Xue Jin Zhan. 2012 Aug;43(4):251-6. Sheng Li Ke Xue Jin Zhan. 2012. PMID: 23189617 Review. Chinese.
-
miRNA Expression Profiles of HPV-Infected Patients with Cervical Cancer in the Uyghur Population in China.PLoS One. 2016 Oct 20;11(10):e0164701. doi: 10.1371/journal.pone.0164701. eCollection 2016. PLoS One. 2016. PMID: 27764149 Free PMC article.
-
Deregulation of miR-21 and miR-29a in Cervical Cancer Related to HPV Infection.Microrna. 2019;8(2):110-115. doi: 10.2174/2211536607666181017124349. Microrna. 2019. PMID: 30332981
-
Systematic review of circulating MICRORNAS as biomarkers of cervical carcinogenesis.BMC Cancer. 2022 Aug 6;22(1):862. doi: 10.1186/s12885-022-09936-z. BMC Cancer. 2022. PMID: 35933332 Free PMC article.
Cited by
-
Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review.Discov Oncol. 2022 Sep 24;13(1):91. doi: 10.1007/s12672-022-00551-9. Discov Oncol. 2022. PMID: 36152065 Free PMC article. Review.
-
The Dysregulation of MicroRNAs in the Development of Cervical Pre-Cancer-An Update.Int J Mol Sci. 2022 Jun 27;23(13):7126. doi: 10.3390/ijms23137126. Int J Mol Sci. 2022. PMID: 35806128 Free PMC article. Review.
-
MiR-27a-3p Regulated the Aggressive Phenotypes of Cervical Cancer by Targeting FBXW7.Cancer Manag Res. 2020 Apr 29;12:2925-2935. doi: 10.2147/CMAR.S234897. eCollection 2020. Cancer Manag Res. 2020. PMID: 32431539 Free PMC article.
-
Anti-tumor activities of probiotics in cervical cancer.J Ovarian Res. 2020 Jun 11;13(1):68. doi: 10.1186/s13048-020-00668-x. J Ovarian Res. 2020. PMID: 32527332 Free PMC article. Review.
-
Screening for High-Risk Human Papillomavirus Reveals HPV52 and HPV58 among Pediatric and Adult Patient Saliva Samples.Dent J (Basel). 2024 Feb 29;12(3):56. doi: 10.3390/dj12030056. Dent J (Basel). 2024. PMID: 38534280 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical